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Abstract
Background:  Evidence suggests that gender differences exist in the severity of many
immunological diseases and their response to glucocorticosteroid treatment. In this report, we
have used a murine model of ovalbumin-induced lung inflammation to address whether gender
could affect the systemic response, airway inflammation and hyperreactivity and their responses to
budesonide.
Results: Following an acute ovalbumin challenge, actively sensitised BALB/c mice developed a
time-dependent increase in interleukin-4 and interleukin-5 production and inflammatory cell influx
into bronchoalveolar lavage fluid. Apart from an increased number of lymphocytes in female mice
at day 3 post-challenge, none of the above parameters were affected by gender. Blood leukocyte
numbers were also unaffected, whereas a two-fold increase in total serum immunoglobulin E was
observed in female mice. Budesonide, given intranasally, did not affect the blood parameters, but
dose-dependently inhibited the pulmonary inflammation and airway hyperreactivity in both male
and female mice. Female mice were slightly less sensitive to budesonide's inhibitory action on
interleukin-5 production and the development of airway hyperreactivity.
Conclusions: Our results suggest that, apart from a 2-fold increase in serum immunoglobulin E
levels observed in female mice, gender is not a major factor in the present murine model of
ovalbumin-induced lung inflammation. In contrast, gender might slightly influence the potency of
test compounds such as steroids.
Background
The immune system shows a marked gender dimorphism,
which is reflected by the different susceptibilities of men
and women to specific immunological disorders. As such,
men have a higher risk of bacterial and viral infections
[1,2], whereas women seem to be more susceptible to
autoimmune or inflammatory diseases [3]. Bronchial
asthma is a chronic inflammatory disease of the airways,
a prominent feature of which is an intense infiltration of
inflammatory cells. Of these, T-cells of the T helper 2 sub-
type and eosinophils are believed to be the main protago-
nists inflicting injury to the bronchial mucosa. This
damage contributes to bronchial obstruction and airway
hyperreactivity observed in asthmatics. Inhaled corticos-
teroids remain the anti-inflammatory drugs of choice in
the treatment of this disease [4].
We and other laboratories have developed murine models
of allergen-induced lung inflammation that demonstrate
some of the characteristic features of human asthma [5-9].
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However, female and male mice are used indifferently in
these models and the possible influence of gender on the
allergen-induced lung inflammation has never been stud-
ied in detail. One study addressing this question has
shown that the systemic allergic response to ovalbumin
(i.e. serum immunoglobulin E and blood eosinophil lev-
els) was greater in female than male mice. However, a sys-
tematic study of the lung inflammation following local
allergen challenge was not performed [10]. In this report
we have used a previously characterised model of ovalbu-
min-induced asthma in BALB/c mice [9] to investigate
whether gender could influence development of the
inflammatory response, monitored by bronchoalveolar
lavage parameters of inflammation and airway hyperreac-
tivity as well as total serum immunoglobulin E levels and
blood inflammatory cells numbers. Since published work
suggests that the action of glucocorticosteroids can also be
gender dependent [3,11], we have also studied the effect
of budesonide, a glucocorticosteroid widely used to treat
human asthma.
Results
Bronchoalveolar lavage parameters of inflammation
In both female and male mice, ovalbumin-induced bron-
choalveolar lavage inflammatory cell infiltration was fol-
lowed up to 14 days after the challenge (Figure 1). An
early neutrophil influx was observed, peaking at day 1 and
going back to baseline at day 3. This early neutrophil
influx was followed by an increase in eosinophil num-
bers, starting at day 1, peaking at day 3 and returning to
baseline by day 14. Lymphocyte numbers increased by
day 1, peaked at day 3 and came back to baseline by day
14. No significant variation in the macrophage numbers
was observed. The time course of ovalbumin-induced pro-
duction of the bronchoalveolar lavage T-helper 2
cytokines (interleukin-5 and interleukin-4) was also stud-
ied. Both cytokines showed the same kinetic pattern,
appearing at 6 hours, peaking at day 1 and coming back
to baseline by day 2 (Figure 1). However, approximately
10-fold more interleukin-4 was produced compared to
interleukin-5. The overall kinetics for each of the parame-
ters studied was similar for both genders, with the only
difference being a significant increased number of lym-
phocytes in female mice at day 3. In sham sensitised mice
(Alum only) challenged with ovalbumin, no bronchoal-
veolar lavage inflammation was observed (data not
shown).
At day 1 post-challenge, budesonide dose-dependently
inhibited the ovalbumin-induced increase in neutrophil,
eosinophil and lymphocyte numbers in the bronchoalve-
olar lavage. Though budesonide treatment had no signifi-
cant effect on the macrophage numbers when compared
with vehicle treated animals, when male and female were
compared a significant decrease in macrophage numbers
was observed in female mice treated with 3 mg/kg budes-
onide (Figure 2).
A significant inhibition of all other inflammatory cell
types infiltrating the airways was observed at a dose of 0.3
mg/kg budesonide in the female group whereas this dose
had no significant effect in males. However, when com-
paring between genders, no significant differences were
found. The same degree of inhibition for all the inflam-
matory cells was obtained at a dose of 3 mg/kg in both
genders. The ovalbumin-induced increase in interleukin-4
levels in the bronchoalveolar lavage was inhibited dose
dependently by budesonide with similar efficacy in both
female and male animals (Figure 2). The allergen-induced
increase in interleukin-5 levels was also dose-dependently
inhibited by budesonide. However, female mice were sig-
nificantly less sensitive to the budesonide inhibition at a
dose of 0.3 mg/kg (Figure 2).
As observed one day after the challenge, on day 2 post
challenge, a dose of 0.3 mg/kg budesonide significantly
inhibited the neutrophil, eosinophil and lymphocyte
numbers only in female mice. However, when comparing
between genders, only the eosinophil numbers were sig-
nificantly different. At a dose of 3 mg/kg budesonide
inhibited the cellular inflammation with equal efficacy in
both genders (Figure 3).
Peripheral blood cell counts and total serum 
immunoglobulin E levels
In order to assess the possible gender differences in sys-
temic inflammation, female and male mice were sacri-
ficed one day after the aerosol challenge and whole blood
inflammatory cell counts and total serum immunoglobu-
lin E levels determined. No gender differences were
observed in any of the cell types counted (i.e. neutrophils,
eosinophils, monocytes and lymphocytes). In contrast,
when compared with male mice, a two-fold increase in
the total serum immunoglobulin E was measured in
female mice (Table 1). In sham sensitised animals (Alum
only), the baseline levels of total serum immunoglobulin
E were similar in female (1.8 ± 0.5 µg/ml) and male mice
(1.4 ± 0.2 µg/ml). In both male and female mice, budeso-
nide had no significant effect on the blood inflammatory
cell numbers or total serum immunoglobulin E levels
(data not shown).
Airway reactivity
Twenty four hours after challenge with ovalbumin there
was a significant increase in airway reactivity to aero-
solised methacholine when compared with PBS-chal-
lenged animals. In both PBS- and ovalbumin-challenged
animals, no significant gender differences in the baseline
airway response or in the airway response following meth-
acholine challenge was observed (Figure 4A). In bothBMC Pharmacology 2004, 4 http://www.biomedcentral.com/1471-2210/4/4
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Time course of bronchoalveolar lavage inflammatory cell infiltration and interleukin-4 and interleukin-5 levels following ovalbu- min challenge Figure 1
Time course of bronchoalveolar lavage inflammatory cell infiltration and interleukin-4 and interleukin-5 levels following ovalbu-
min challenge. Actively sensitised female and male mice were challenged with a nebulised solution of ovalbumin and sacrificed 
at different time points for bronchoalveolar lavage. Data are expressed as mean ± standard error of 6–8 mice per group. # 
indicates significance when comparing male and female mice at the same time point.
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genders, the hyperreactivity to methacholine was unaf-
fected by 0.3 mg/kg of budesonide. When given at a dose
of 3 mg/kg, budesonide fully inhibited airway hyperreac-
tivity in male mice with only partial reduction observed in
female mice (Figure 4A). This gender difference was fur-
ther exemplified by the concentration of methacholine
Effect of budesonide treatment on bronchoalveolar lavage inflammatory cell infiltration and interleukin-5 and interleukin-4 lev- els at day 1 post challenge Figure 2
Effect of budesonide treatment on bronchoalveolar lavage inflammatory cell infiltration and interleukin-5 and interleukin-4 lev-
els at day 1 post challenge. Actively sensitised female and male mice were treated intranasally with vehicle (n = 10), 0.3 mg/kg 
(n = 10) or 3 mg/kg (n = 10) of budesonide and challenged with ovalbumin 1 hour later. Data are expressed as mean ± standard 
error. * and # indicate significance against the vehicle-treated group and when comparing male and female mice, respectively.
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that produced a three-fold increase above baseline
(ED300) (Figure 4B). No increase in airway reactivity was
observed in sham sensitised mice (Alum only) challenged
with ovalbumin (data not shown).
Effect of budesonide treatment on bronchoalveolar lavage inflammatory cell infiltration at day 2 post challenge Figure 3
Effect of budesonide treatment on bronchoalveolar lavage inflammatory cell infiltration at day 2 post challenge. Actively sensi-
tised female and male mice were treated intranasally with vehicle (n = 8), 0.3 mg/kg (n = 8) or 3 mg/kg (n = 8) of budesonide 
and challenged with ovalbumin 1 hour later. Data are expressed as mean ± standard error. * and # indicate significance against 
the vehicle-treated group and when comparing male and female mice, respectively.
Table 1: Comparison of blood inflammatory cell numbers and total serum immunoglobulin E levels of female and male mice one day 
after the aerosol challenge
Female (n = 10) Male (n = 10)
Neutrophils (105/ml) 100.1 ± 11.6 99.6 ± 15.2
Eosinophils (105/ml) 56.4 ± 12.8 37.9 ± 9.4
Monocytes (105/ml) 28.9 ± 3.7 23.5 ± 2.9
Lymphocytes (105/ml) 100.1 ± 10.2 123.9 ± 18.2
Total serum immnoglobulin E (µg/ml) 22.8 ± 8.1 9.7 ± 1.8*
Data are expressed as mean ± standard error. Significance, indicated by * is against female mice.
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Discussion
Allergen-driven murine models of lung inflammation are
widely used to study the mechanisms of human asthma
[12,13]. However, little consideration has been given to
the potential effect of gender. In this study we demon-
strate that, despite a two-fold increase in total serum
immunoglobulin E present in female mice, following
acute allergen challenge, actively sensitised BALB/c mice
develop lung inflammation and hyperreactivity that is
independent of gender. In addition, our results suggest
that gender may slightly influence the potency of anti-
inflammatory drugs such as budesonide.
The aim of this study was to extend previously published
work that suggested gender differences in the develop-
ment of the allergic response induced by ovalbumin in
Measurement of airway hyperreactivity to aerosolised methacholine and effect of budesonide treatment Figure 4
Measurement of airway hyperreactivity to aerosolised methacholine and effect of budesonide treatment. Actively sensitised 
female and male mice were treated intranasally with vehicle and challenged with PBS (n = 8) or ovalbumin (n = 10) one hour 
later. Different groups of animals were intranasally treated with 0.3 mg/kg (n = 10) or 3 mg/kg (n = 10) of budesonide and chal-
lenged with ovalbumin one hour after. Airway hyperreactivity to aerosolised methacholine was measured 24 hours after the 
challenge using whole body plesthysmography. ED300 values for methacholine (panel B) were calculated from the dose-
response display in panel A by log-linear interpolation. Data are expressed as mean ± standard error. * and # indicate signifi-
cance against the vehicle-treated group and when comparing male and female mice, respectively.
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BALB/c mice [10]. In that study, using a similar model to
the one described here, the authors showed that actively
sensitised and challenged female mice had higher levels of
serum immunoglobulin E and blood eosinophil
numbers. In addition, in vitro restimulation of lung
homogenates with ovalbumin induced an increased pro-
duction of T-helper 2 cytokines in female versus male
mice. However, airway inflammatory cell infiltrate and
hyperreactivity, two main characteristics of human
asthma, were not studied [10].
Here, we confirm the increased levels of total serum
immunoglobulin E in female mice, and demonstrate a
trend for increased eosinophil numbers in female mice,
albeit not significant. However, in our study, gender did
not affect T-helper 2 cytokine production which is in con-
tradiction to previously published results. Reasons for this
difference are unknown, although cytokine levels in
response to in vivo allergen challenge were measured
whereas Seymour and colleagues [10] studied cytokine
production following in vitro restimulation.
It is interesting to note that despite a two-fold increase in
serum immunoglobulin E, female mice develop a similar
degree of lung inflammation and hyperreactivity as male
mice when challenged locally with the allergen. Immu-
noglobulin E plays a central role in allergic diseases such
as asthma [14] and its role in the development of airway
inflammation [15] and airway hyperreactivity [16] in
murine models of allergic asthma has been confirmed.
Therefore, one might expect increased airway inflamma-
tion in female versus male mice. However, the importance
of immunoglobulin E in murine asthma models has been
shown to be dependent on the method of allergen sensi-
tisation [17]. Immunoglobulin E seems to play a minor
role in the development of airway inflammation and air-
way hyperreactivity in mice that have been systemically
sensitised and challenged via the airways [18]. Taken
together, our data demonstrate that, apart form an
increased level of serum immunoglobulin E in female
mice, there is no gender dependency on airway inflamma-
tion and hyperreactivity following an acute allergen chal-
lenge in actively sensitised mice.
The second aspect of this work was to test whether gender
could influence the efficacy of anti-inflammatory agents
such as budesonide, an inhaled glucocorticosteroid which
is widely used as an anti-inflammatory agent for the treat-
ment of asthma. We felt it important to study this aspect
for two reasons. First, evidence suggests that gender could
modulate glucocorticosteroid sensitivity [3,11]. Second,
murine models of asthma are often used as a primary
model for evaluating the in vivo efficacy of potential anti-
inflammatory drugs, like steroids, for the treatment of
asthma [5,19,20]. However, researchers have used either
male or female mice and to our knowledge no study has
addressed the possible gender influence on steroid effi-
cacy in these murine models. Our data suggests that gen-
der could affect the potency of steroids when studying
allergen-induced airway inflammation and hyperreactiv-
ity. When tested against airway hyperreactivity, budeso-
nide treatment was not able to fully reverse this parameter
in female mice, whereas a complete reversal was observed
in males. Similarly, a significant inhibition of allergen-
induced interleukin-5 production on day 1 and eosi-
nophilia on day 2 was observed at a dose of 0.3 mg/kg of
budesonide in females only. Moreover, when used at a
dose of 3 mg/kg, a similar degree of inhibition was
observed independent of gender. Taken together, our data
suggests that although gender might affect the potency of
anti-inflammatory drugs such as inhaled steroids, these
differences remains subtle.
Conclusions
In summary, we have shown that despite a two-fold
increase in serum immunoglobulin E in females, actively
sensitised BALB/c mice display a similar degree of airway
inflammation and hyperreactivity induced by aerosol
challenge in both genders. In contrast, gender may influ-
ence sensitivity to inhaled steroids such as budesonide.
This suggests that while gender is not important when
studying airway inflammation, it does influence the sys-
temic response and may have a minor influence on the
potency of test compounds such as steroids.
Methods
Animals
Six week old female and male BALB/c mice were obtained
from Charles River (Margate, UK). All animals were
housed in plastic cages (6–10 animals per cage) in an air-
conditioned room at 24°C with a 12 hours light-dark
cycle. Food (RM1 rodent diet, Lillico, Surrey, UK) and tap
water were available ad libitum. All animals were acclima-
tised for a period of at least 7 days upon arrival before any
experimental work began. The studies conformed to the
UK Animals (scientific procedures) Act 1986.
Experimental protocol
Mice were immunized intraperitoneally with 10 µg of
ovalbumin, (grade V, Sigma, Poole. UK) in 0.2 ml of
Alum or with Alum alone (Serva, Heidelberg, Germany)
on day 0 and day 14. On day 21, animals were exposed,
for 20 minutes, to an aerosol of ovalbumin in phosphate-
buffered saline (PBS, 50 mg/ml) or PBS alone. The exper-
imental protocol and all the techniques mentioned there-
after have been previously described in details [9,21].
Assessment of airway inflammation
Terminal anaesthesia was induced with pentobarbitone
sodium (60 mg/kg, intraperitoneally). The trachea wasBMC Pharmacology 2004, 4 http://www.biomedcentral.com/1471-2210/4/4
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cannulated and bronchoalveolar lavage was performed by
injecting 4 times 0.3 ml of PBS into the lung via the
trachea. Total cell counts were determined and cytospin
preparation (Shandon Scientific Ltd, Cheshire, UK) were
made. Cells were stained with Dif-Quik (Baxter Dade AG,
Dudingen, Switzerland) and a differential count of 200
cells performed using standard morphological criteria.
The remaining lavage fluids were centrifuged at 400 × g for
10 minutes, the supernatant was aliquoted and stored at -
80°C for cytokine levels determination using commer-
cially available kits (Endogen, Wolburn, MA, USA).
Assessment of blood cell numbers and serum 
immunoglobulin E levels
One day after the aerosol challenge, mice were anesthe-
tised and blood was taken from the aorta. Three hundred
µl of blood was used for serum preparation and determi-
nation of total immunoglobulin E levels [9]. From the
remaining blood sample, total white blood cells numbers
were determined, and peripheral blood smears prepared.
Differential cell types were determined on blood smears,
stained with Diff-Quick by randomly counting 300
leukocytes.
Determination of airway reactivity
Airway hyperreactivity was measured using barometric
plesythmography and whole body plesythmography [9].
One day following aerosol challenge, conscious mice were
placed in the plesythmography chamber (Buxco Electron-
ics, Sharon, CT, USA) and baseline respiratory parameters
measured for 5 minutes. Animals were then sequentially
exposed to aerosolised PBS and increasing doses of meth-
acholine (0.03 to 0.3 M). Nebulisation was performed for
2 minutes and the airway response, Penh, was measured
for the following 5 minutes and expressed as total area
under the curve. For comparison between groups a sig-
moidal curve was fitted to the dose-response data and
used to calculate the concentration of methacholine that
produced a three-fold increase above baseline Penh
(ED300).
Budesonide treatment
Mice were treated via the intranasal route, under haloth-
ane/oxygen/nitrous oxide anaesthesia, one hour before
the challenge with a suspension of 0.3 or 3 mg/kg of
budesonide in PBS containing 2% dimethyl sulfoxide.
Control mice received 50 µl of vehicle.
Statistical analysis
Data are expressed as means ± standard error and statisti-
cal significance (P < 0.05) was determined using a Mann-
Whitney test.
List of abbreviations
PBS, phosphate-buffered saline.
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